Yea Christopher sold KALV
July 9, 2025 · Form 4 insider transaction
Yea Christopher sold 30,250 shares of KalVista Pharmaceuticals Inc at $15.69 per share, a transaction worth $474.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
30,250
Price
$15.69
Total value
$474.7K
InsiderYea Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 9, 2025
Filing dateJuly 10, 2025
Shares owned after127,939
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of PSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.